Scientific Publications
Topline Results for Darigabat in Phase 1 Acute Anxiety Clinical Trial Presentation
Feb 15, 2022
Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhuman Primates
Dec 08, 2021
CVL-231: Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
Dec 08, 2021
Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients with Schizophrenia Presentation
Jun 29, 2021
Presentations at Movement Disorder Society Congress 2020: Analyses of Parkinson’s Disease Medication
Oct 01, 2020
View PDF 1.4 MB
Presentation at 2020 Epilepsy Foundation Pipeline Conference: CVL-865: The Journey to REALIZE
Aug 27, 2020